Microtia is a congenital auricle dysplasia with a high incidence and tissue engineering technology provides a promising strategy to reconstruct auricles. We previously described that the engineered cartilage constructed from
microtia chondrocytes exhibited inferior levels of biochemical and biomechanical properties, which was proposed to be resulted from the decreased migration ability of
microtia chondrocytes. In the current study, we found that
Rho GTPase members were deficient in
microtia chondrocytes. By overexpressing RhoA, Rac1 and CDC42, respectively, we further demonstrated that RhoA took great responsibility for the decreased migration ability of
microtia chondrocytes. Moreover, we constructed
PGA/PLA scaffold-based cartilages to verify the chondrogenic ability of RhoA overexpressed
microtia chondrocytes, and the results showed that overexpressing RhoA was of limited help to improve the quality of
microtia chondrocyte engineered cartilage. However, co-culture of ADSCs significantly improved the biochemical and biomechanical property of engineered cartilage. Especially, co-culture of RhoA overexpressed
microtia chondrocytes and ADSCs produced an excellent effect on the wet weight, cartilage-specific extracellular matrix and biomechanical property of engineered cartilage. Furthermore, we presented that co-culture of RhoA overexpressed
microtia chondrocytes and ADSCs combined with human ear-shaped
PGA/PLA scaffold and
titanium alloy stent fabricated by CAD/CAM and 3D printing technology effectively constructed and maintained auricle structure in vivo. Collectively, our results provide evidence for the essential role of RhoA in
microtia chondrocytes and a developed strategy for the construction of patient-specific tissue-engineered auricular cartilage.